Impact Factor 5.511
2017 JCR, Clarivate Analytics 2018

Among the world's top 10 most-cited Immunology journals

Original Research ARTICLE Provisionally accepted The full-text will be published soon. Notify me

Front. Immunol. | doi: 10.3389/fimmu.2019.00244

Thioredoxin modulates Protein Arginine Deiminase 4 (PAD4)-catalyzed citrullination

  • 1University of Massachusetts Medical School, United States

Protein citrullination plays a crucial role in the pathophysiology of numerous autoimmune disorders including Rheumatoid Arthritis (RA). Recently, there has been a growing interest in investigating the physiological regulators of the protein arginine deiminases (PADs), which catalyze this modification. Apart from calcium, it is well documented that a reducing environment activates the PADs. Although the concentration of thioredoxin (hTRX), an oxidoreductase that maintains the cellular reducing environment, is elevated in RA patients, its contribution towards RA progression or PAD activity has not been explored. Herein, we demonstrate that hTRX activates PAD4. Kinetic characterization of PAD4 using hTRX as the reducing agent yielded parameters that are comparable to those obtained with the non-physiological reducing agent DTT, suggesting the importance of hTRX in PAD regulation under physiological conditions. Furthermore, we show that various hTRX mutants, including redox inactive hTRX variants, are capable of activating PAD4. These data demonstrate that hTRX activates PAD4 via a mechanism that does not require oxidoreductase activity. Indeed, we observed non-covalent interactions between PAD4 and hTRX variants, and propose that these redox-independent interactions are sufficient for hTRX mediated PAD4 activation.

Keywords: thioredoxin, pad4, citrullination, Rheumatoid arthritis, Autoantibodies, NETosis.

Received: 09 Jul 2018; Accepted: 28 Jan 2019.

Edited by:

Uday Kishore, Brunel University London, United Kingdom

Reviewed by:

Huw Lewis, GlaxoSmithKline (Italy), Italy
Gunnar Houen, State Serum Institute (SSI), Denmark  

Copyright: © 2019 Nagar and Thompson. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Dr. Paul Thompson, University of Massachusetts Medical School, Worcester, MA 01655, Massachusetts, United States, Paul.Thompson@umassmed.edu